Clinical relevance and predictors of anti-natalizumab antibodies in multiple sclerosis: A real-world retrospective cohort study.

Mult Scler J Exp Transl Clin · 2026 · PMC13036329 · PMID 41924393

Europe PMC DOI

hedged sentence

0.5000

closest p · 10.0× alpha

0.5000

boldest claim

The sentences

did not reach statistical significancep > 0.5not close (p > 0.1)

33.70 ± 9.10), although these differences did not reach statistical significance ( p > 0.5).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.